Xeris Biopharma: HC Wainwright raises Buy rating, PT to $10.

viernes, 9 de enero de 2026, 8:33 am ET1 min de lectura
XERS--

Xeris Biopharma: HC Wainwright raises Buy rating, PT to $10.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios